HSIC
Price
$70.06
Change
-$0.48 (-0.68%)
Updated
May 14, 04:59 PM (EDT)
Capitalization
9.7B
83 days until earnings call
MCK
Price
$682.26
Change
-$5.52 (-0.80%)
Updated
May 14, 04:59 PM (EDT)
Capitalization
70.55B
77 days until earnings call
Ad is loading...

HSIC vs MCK

Header iconHSIC vs MCK Comparison
Open Charts HSIC vs MCKBanner chart's image
Henry Schein
Price$70.06
Change-$0.48 (-0.68%)
Volume$38.7K
Capitalization9.7B
McKesson
Price$682.26
Change-$5.52 (-0.80%)
Volume$9.34K
Capitalization70.55B
HSIC vs MCK Comparison Chart
Loading...
HSIC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MCK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HSIC vs. MCK commentary
May 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HSIC is a Buy and MCK is a Hold.

Ad is loading...
COMPARISON
Comparison
May 15, 2025
Stock price -- (HSIC: $70.54 vs. MCK: $687.78)
Brand notoriety: HSIC: Not notable vs. MCK: Notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: HSIC: 99% vs. MCK: 100%
Market capitalization -- HSIC: $9.7B vs. MCK: $70.55B
HSIC [@Medical Distributors] is valued at $9.7B. MCK’s [@Medical Distributors] market capitalization is $70.55B. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The average market capitalization across the [@Medical Distributors] industry is $10.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HSIC’s FA Score shows that 0 FA rating(s) are green whileMCK’s FA Score has 2 green FA rating(s).

  • HSIC’s FA Score: 0 green, 5 red.
  • MCK’s FA Score: 2 green, 3 red.
According to our system of comparison, MCK is a better buy in the long-term than HSIC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HSIC’s TA Score shows that 5 TA indicator(s) are bullish while MCK’s TA Score has 3 bullish TA indicator(s).

  • HSIC’s TA Score: 5 bullish, 4 bearish.
  • MCK’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, MCK is a better buy in the short-term than HSIC.

Price Growth

HSIC (@Medical Distributors) experienced а +6.49% price change this week, while MCK (@Medical Distributors) price change was -3.28% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +0.50%. For the same industry, the average monthly price growth was +9.11%, and the average quarterly price growth was -3.49%.

Reported Earning Dates

HSIC is expected to report earnings on Aug 05, 2025.

MCK is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Medical Distributors (+0.50% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MCK($70.5B) has a higher market cap than HSIC($9.71B). MCK (24.25) and HSIC (23.50) have similar P/E ratio . MCK YTD gains are higher at: 20.816 vs. HSIC (1.936). MCK has higher annual earnings (EBITDA): 4.44B vs. HSIC (877M). MCK has more cash in the bank: 1.98B vs. HSIC (171M). HSIC has less debt than MCK: HSIC (2.74B) vs MCK (7.61B). MCK has higher revenues than HSIC: MCK (302B) vs HSIC (12.3B).
HSICMCKHSIC / MCK
Capitalization9.71B70.5B14%
EBITDA877M4.44B20%
Gain YTD1.93620.8169%
P/E Ratio23.5024.2597%
Revenue12.3B302B4%
Total Cash171M1.98B9%
Total Debt2.74B7.61B36%
FUNDAMENTALS RATINGS
HSIC vs MCK: Fundamental Ratings
HSIC
MCK
OUTLOOK RATING
1..100
2073
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
14
Undervalued
PROFIT vs RISK RATING
1..100
575
SMR RATING
1..100
6297
PRICE GROWTH RATING
1..100
5346
P/E GROWTH RATING
1..100
6540
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MCK's Valuation (14) in the Medical Distributors industry is significantly better than the same rating for HSIC (80). This means that MCK’s stock grew significantly faster than HSIC’s over the last 12 months.

MCK's Profit vs Risk Rating (5) in the Medical Distributors industry is somewhat better than the same rating for HSIC (57). This means that MCK’s stock grew somewhat faster than HSIC’s over the last 12 months.

HSIC's SMR Rating (62) in the Medical Distributors industry is somewhat better than the same rating for MCK (97). This means that HSIC’s stock grew somewhat faster than MCK’s over the last 12 months.

MCK's Price Growth Rating (46) in the Medical Distributors industry is in the same range as HSIC (53). This means that MCK’s stock grew similarly to HSIC’s over the last 12 months.

MCK's P/E Growth Rating (40) in the Medical Distributors industry is in the same range as HSIC (65). This means that MCK’s stock grew similarly to HSIC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HSICMCK
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
50%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
66%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
58%
Bearish Trend 2 days ago
49%
MACD
ODDS (%)
Bullish Trend 2 days ago
47%
Bearish Trend 2 days ago
45%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
55%
Bearish Trend 2 days ago
40%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
48%
Bullish Trend 2 days ago
64%
Advances
ODDS (%)
Bullish Trend 2 days ago
54%
Bullish Trend 8 days ago
67%
Declines
ODDS (%)
Bearish Trend 14 days ago
56%
Bearish Trend 21 days ago
41%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
46%
Aroon
ODDS (%)
Bullish Trend 2 days ago
45%
Bullish Trend 2 days ago
70%
View a ticker or compare two or three
Ad is loading...
HSIC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MCK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BFLY2.380.03
+1.28%
Butterfly Network
BOSC3.990.02
+0.51%
B.O.S. Better Online Solutions
SGRY22.93-0.33
-1.42%
Surgery Partners
IX20.07-0.44
-2.15%
Orix Corp
NRC13.44-0.41
-2.96%
National Research Corp

HSIC and

Correlation & Price change

A.I.dvisor tells us that HSIC and ZYXI have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HSIC and ZYXI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HSIC
1D Price
Change %
HSIC100%
+0.10%
ZYXI - HSIC
24%
Poorly correlated
+0.93%
CAH - HSIC
20%
Poorly correlated
-0.24%
OMI - HSIC
18%
Poorly correlated
+1.12%
COR - HSIC
18%
Poorly correlated
+0.22%
SHTDY - HSIC
11%
Poorly correlated
-0.21%
More

MCK and

Correlation & Price change

A.I.dvisor indicates that over the last year, MCK has been loosely correlated with COR. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if MCK jumps, then COR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MCK
1D Price
Change %
MCK100%
+0.04%
COR - MCK
64%
Loosely correlated
+0.22%
CAH - MCK
48%
Loosely correlated
-0.24%
OMI - MCK
10%
Poorly correlated
+1.12%
SHTDF - MCK
9%
Poorly correlated
N/A
HSIC - MCK
5%
Poorly correlated
+0.10%
More